Stroke Management Market Size to Uplift USD 85.5 Bn by 2034

Stroke Management Market Size, Trends, Companies and AI Impact

The global stroke management market was evaluated at US$ 38.83 billion in 2023 and is expected to attain around US$ 85.5 billion by 2034, growing at a CAGR of 7.44% from 2024 to 2034. The stroke management market is growing because if the stroke is left untreated, the stroke will continue until the brain cells in the affected area of the patient's brain die, causing permanent damage due to the need for stroke management.

Unlock Infinite Advantages: Subscribe to Annual Membership

Market Overview

The stroke management market is rapidly growing due to emergency treatment depending on whether patients have a stroke or a hemorrhagic stroke. During an ischemic stroke, the blood vessels in the brain can become blocked or narrowed. During a hemorrhagic stroke, bleeding occurs in the brain. A stroke occurs when the amount of oxygen reaching the brain is reduced. This can be caused by a blood clot or a blockage in the brain. Immediate emergency treatment can help prevent life-threatening conditions.

Doctors may do blood tests to determine if patients are at risk for bleeding or blood clots, measure the levels of certain drugs in blood (such as those used to treat blood clots), and check for disease. Stroke is the leading cause of long-term disability in adults. About 800,000 Americans have a stroke each year. Early treatment and rehabilitation can significantly reduce the risk of stroke.

• For instance, in 2024, A study published in the journal JAMA Neurology showed that argatroban was associated with better brain function in ischemic stroke patients who suffered early brain damage.

Market Trends

• In December 2023, strengthening stroke prevention as part of the health system through the Ayushman Arogya scheme, project, promoting healthy clean drinking and social interaction at the community level.
• In June 2023, the Public Health Department, GoM, will ensure the efficiency and quality of the activities carried out by the ANGELS initiative. This includes, in addition to basic procedures and facilities, the provision of 24*7 CT scanning facilities with at least one specialist for Face-Arm-Speech-Time (FAST) diagnosis. As part of the MoU, the government will establish new stroke centers shortly and provide doctors with 24/7 CT scans and related thrombolytic drugs.
• In July 2024, NINDS supports a wide range of basic and clinical research to find better ways to prevent, diagnose, and treat stroke and to restore function lost due to stroke. NINDS-supported researchers are working to develop new, better stroke treatments, find ways to restore blood flow to the brain after stroke, and protect the brain from damage during and after stroke.
• In May 2023, the FDA approved 22 AI/ML-enabled technologies for specific guidelines for the diagnosis and rehabilitation of stroke.

AI Integration

AI can analyze and combine clinical data, tests, and imaging to provide personalized recommendations for the best treatments for stroke and provide evidence of operational outcomes. This technology is also being used to treat strokes. Electronic devices that use AI can analyze a patient’s movement patterns and guide them to help improve mobility and function.

It will also help develop programs to help treat speech, language, and vision problems. By analyzing clinical and imaging data, AI may also be able to predict which patients will suffer from depression and cognitive dysfunction after strokes, which causes growth of the stroke management market.

Enhancing Stroke Management through Public Awareness and Efficient EMS Response

Increasing public awareness of stroke symptoms and increasing the availability of emergency medical services (EMS) are important to ensuring that stroke patients receive timely and appropriate treatment. In both outpatient and hospital settings, emergency physicians play a key role in developing and implementing programs to manage hyperacute stroke. Additionally, regular hospital internships and reviews are essential to ensure that hospital staff are prepared and knowledgeable.

One of the best strategies for raising public awareness is to use healthcare professionals and activists with close ties to the local community to educate the public about stroke and appropriate interventions. Increasing awareness of the warning signs of stroke and the need for urgent medical attention can reduce delays in patients seeking emergency care and ultimately improve patient outcomes and hospital operations, leading to an improved stroke management market.

Stem Cell Therapy for Stroke Management

Stem cell therapy represents an opportunity for stroke treatment and offers great potential to speed recovery and improve patient outcomes. Research with mesenchymal stem cells (MSCs), particularly those derived from bone marrow, fat tissue, or the umbilical cord, has shown promising results in initial testing for ischemic and hemorrhagic stroke. Mesenchymal stem cells have been shown to regenerate brain tissue, reduce nerve inflammation, and replace lost nerve cells, making them ideal candidates for regenerative medicine. As stem cell therapies continue to advance, their ability to improve nerve function offers the opportunity to revolutionize the industry, create new avenues for new treatments, and increase medical benefits for stroke patients. This growth is expected to spur innovation and expand the stroke management market for advanced stroke treatments.

• In April 2024, According to the National Institutes of Health, many pre-clinical studies and clinical trials have shown that mesenchymal cells have the ability to treat chronic diseases and neurodegenerative disorders.

Challenges in Stroke Management

The general population’s low awareness of stroke symptoms, lack of access to specialist healthcare providers, and lack of international collaboration pose major challenges to stroke management. Global health insecurity and financial barriers to stroke prevention, including limited access to essential medicines, hinder efforts to address the risk of the condition and prevent stroke. In addition, lack of access to specialist stroke care, low rates of stroke, and inadequate training further limit the availability of effective treatment. These issues limit the expansion of the stroke management market and create challenges for timely diagnosis, effective treatment, and long-term prevention. Addressing these challenges is critical to unlocking economic growth and improving patient outcomes worldwide.

Regional Insights

Advancements in Stroke Care Drive Market Growth in North America

North America accounted for a major stroke management market share, with over 795,000 stroke cases in the United States in 2022, of which approximately 610,000 are first-time strokes. In the United States, someone has a stroke every 40 seconds. In this country, someone dies from a stroke every 3 minutes and 11 seconds. Approximately 87 percent of strokes are ischemic, where blood flow to the brain is blocked. High blood pressure, high cholesterol, smoking, obesity, and diabetes are risk factors for stroke in this region.

One in three adults in the US is at risk for at least one of these conditions. Of the 5,533 emergency departments in the US, 2,446 (44%) were identified as stroke centers, of which 297 were Comprehensive stroke centers, 14 were Thrombectomy - capable Stroke centers, 1,459 were primary stroke centers, and 678 were Acute Stroke Ready Hospitals. Research and clinical support from teaching hospitals in the United States have improved outcomes for patients after stroke, including reduced mortality rates. Based on technology, medicine is exploring new treatments to improve survival and quality of life for stroke patients.

For Instance,

• In June 2024, Siemens Healthineers and the World Stroke Organization (WSO) announced a two-year partnership to develop the stroke workforce and improve stroke treatment and care.

Surge in Stroke Management Advancements Drives Market Growth in Asia Pacific

Asia Pacific is expected to witness significant growth in the stroke management market during the forecast period, driven by advances in acute management strategies (IV t-PA thrombolysis and mechanical thrombectomy) for AIS across the region over the past decade. Coordinate various stroke groups to improve the care of stroke patients. APSO is an international non-profit organization comprised of national stroke societies, stroke organizations, and individuals whose primary purpose is to improve stroke care in the Asia Pacific region by encouraging, supporting, and organizing international research projects and subsequently sharing the results. The large number of stroke diagnostic trials and research conducted in the Asia-Pacific region has increased significantly as a result of international collaboration and cooperation. Raise awareness of stroke prevention and increase access to care. ASIR in ischemic stroke is increasing in Asia, leading to the growth of the stroke management market in this region.

For Instance,

• In October 2024, The Stroke Association of India (ISA) launched Mission Brain Attack, an initiative to increase awareness, education, and training of doctors on stroke prevention, emergency treatment testing, and rehabilitation. “Each One Teach One” report on stroke risk across India, highlighting the urgent need for specialized training and resources to improve stroke care nationwide.

Segmental Insights

By Type

The diagnostic segment dominated the global market and is expected to remain dominant during the stroke management market forecast period as accurate diagnosis is essential for the selection of appropriate stroke treatments such as intravascular tissue therapy with plasminogen activator (IV tPA) or endovascular mechanical thrombectomy treatment. Gold-standard imaging techniques such as CT and MRI. This device allows first responders to assess stroke earlier when responding to medical emergencies in the field. Prompt initiation of thrombolytic and endovascular therapy is important for optimal outcomes. Another technology used for the rapid detection of stroke utilizing blood-based biomarkers and novel portable devices employing imaging methods such as volumetric impedance phase-shift spectroscopy, microwave tomography, and Doppler ultrasound.

By Application

The ischemic stroke segment dominated the global stroke management market share and is anticipated to continue this trend during the forecast period, as ischemic stroke is caused by atherosclerosis, it can cause fatty deposits and cholesterol plaques to build up in the arteries. An ischemic stroke occurs when blood flow to a part of the brain is blocked or reduced. This prevents the brain tissue from being deprived of oxygen and nutrients. Ischemic stroke accounts for approximately 87 percent of all strokes and has a high long-term risk of recurrence. More than 58 percent of ischemic strokes each year occur in people under the age of 70.

Latest Announcements by Industry Leaders

• In July 2024, JLK announced that it had entered the U.S. market with its intelligence-based stroke diagnostic solution. The South Korean company, which has world-class technology for stroke diagnostics, is now accelerating its entry into the U.S. market.
• In August 2024, Merck announced the initiation of Shorespan-007, a Phase 3 clinical study evaluating bomedemstat, an investigational oral lysine-specific demethylase 1 (LSD1) inhibitor, for the treatment of critically ill patients with cytoreductively untreated thrombocythemia (ET).

Recent Developments in Stroke Management Market

• In October 2024, On World Stroke Day, Punjab Health Minister Dr Balbir Singh announced the transformation of the collaboration between the Government of Punjab, Christian Medical College (CMC), Ludhiana and Medtronic India Private Limited. This public-private partnership is the first of its kind in India that aims to address the growing problem of stroke in Punjab by developing a comprehensive stroke care system that enables timely and effective treatment.
• In September 2024, Gravity Medical Technology, a leader in stroke technology, announced the initiation of the GRASSROOT (Gravity Stent Retrieval System for Large Vessel Occlusion Stroke Reperfusion Trial) trial in India. The trial aims to enroll 60 patients to study the safety and efficacy of the Supernova stent retriever.
• In September 2024, Stryker, a global leader in medical technology, today announced that it has completed the acquisition of NICO Corporation, a specialty company in the field of oncology surgery and minor surgery for intracerebral hemorrhage (ICH) surgery. The acquisition further strengthens Stryker’s commitment to neurotechnology through oncology and stroke care.
• In October 2023, Global healthcare leader Royal Philips and the World Stroke Organization (WSO) announced a two-year partnership to improve access to quality stroke care.

Top Companies in Stroke Management Market

• JLK
• Heuron Co., Ltd.
• General Electric Company
• iSchemaView, Inc.
• Viz.ai, Inc.
• Merck & Co. Inc
• VasSol Inc.
• Aidoc
• Cardinal Health
• NeuraSignal, Inc.
• Brainomix
• Bristol-Myers Squibb Company
• Boston Scientific Corporation
• Abbott Laboratories
• METHINKS
• Qure.ai
• Siemens AG
• B. Braun SE
• Koninklijke Philips N.V
• Deepnoid Co., Ltd.
• Medtronic

Segments Covered in the Stroke Management Market

By Type

• Diagnostics
  • Magnetic Resonance Imaging
  • Carotid Ultrasound
  • Cerebral Angiography
  • Electrocardiography
  • Echocardiography
  • Others
• Therapeutics
  • Type
    • Tissue Plasminogen Activator
    • Anticoagulant
    • Antiplatelet
    • Antihypertensive
• Software

By Application

• Ischemic Stroke
• Haemorrhagic Stroke

By Geography

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America